
Will you be attending the 3rd Annual Obesity & Weight Loss Drug Development Summit in Boston on July 14th to 16th, 2025?
Don’t miss our session on July 15th, Optimizing Patient Adherence in Clinical Trials: Behavioral Evaluation, Risk Prediction, and Personalized Digital Interventionism, which will be presented by Nicholas Alp, MD, PhD, Chief Medical Officer at Clinical ink.
Let’s schedule a time to chat. Click the button below and fill out the form. Our team will be in touch to schedule a meeting during the conference.